type-2-diabetes

Documents about type-2-diabetes

• IL-1RA, Acute Exercise, and Beta-cell Function#160282ClinicalTrials.gov
• Nutrition-Focused Approach During CGM Initiation: A Qualitative Study#172461ClinicalTrials.gov
• Effect of GLP-1 on Angiogenesis#184819ClinicalTrials.gov
• Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea#136217ClinicalTrials.gov
• A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes#146377ClinicalTrials.gov
• Addressing gender and social inequities: the challenge of metabolic control in women with type 2 diabetes in Quito#147595HAL (France)
• Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea#162431ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin#180335ClinicalTrials.gov
• A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients#184783ClinicalTrials.gov
• Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin#184793ClinicalTrials.gov
• A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in Indian Patients Who Were Recently Diagnosed With Type 2 Diabetes (T2D)#184817ClinicalTrials.gov
• Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)#158128ClinicalTrials.gov
• Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction#172496ClinicalTrials.gov
• 20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up#121502ClinicalTrials.gov
• Effect of Short Course of Glucocorticoid in Patients With Diabetes Mellitus(DM) Type 2#146376ClinicalTrials.gov
• Effects of Metformin Therapy on Pancreatic and Hepatic Fat Content in Patients of Type 2 Diabetes Mellitus#146418ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus#184805ClinicalTrials.gov
• The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly#121266ClinicalTrials.gov
• Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver#148676ClinicalTrials.gov
• Prebiotics and Metformin Improve Gut and Hormones in Type 2 Diabetes in Youth (MIGHTY-fiber)#162387ClinicalTrials.gov
• RCT Glargine vs NPH for Treatment of DM in Pregnancy#171298ClinicalTrials.gov
• The Effect of Cinnamon Cassia on Diabetes Control and Cardiometabolic Risk Factors in Adults With Type 2 Diabetes Mellitus#175032ClinicalTrials.gov
• A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese#160317ClinicalTrials.gov
• Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients#126061ClinicalTrials.gov
• Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients#160295ClinicalTrials.gov
• Effects of Replacing Diet Beverages With Water on Weight Maintenance of Type 2 Diabetic Obese Women: 18 Months Follow up#175061ClinicalTrials.gov
• Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone#18801ClinicalTrials.gov
• Effect of Metformin on Exercise-induced Lipolysis#28560ClinicalTrials.gov
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients#67835ClinicalTrials.gov
• Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin#123391ClinicalTrials.gov
• Levemir-Body Composition and Energy Metabolism#123424ClinicalTrials.gov
• Glycemic Evaluation of Novel Staple Foods#127755ClinicalTrials.gov
• Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis#127810ClinicalTrials.gov
• Human Intestinal Peptides Evaluation and Research#136242ClinicalTrials.gov
• Developing Resiliency and Exercise Using AI-based Messaging#143740ClinicalTrials.gov
• Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)#146340ClinicalTrials.gov
• Study of Renal Blood Flow During Human Endotoxemia#146359ClinicalTrials.gov
• Use of Nutraceuticals in Clinical Practice#148604ClinicalTrials.gov
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin#148647ClinicalTrials.gov
• A HR20031 FE Study on Healthy Subjects#172508ClinicalTrials.gov
• Glucophage XR® Observational Study#175067ClinicalTrials.gov
• Arginase Inhibition in Ischemia-reperfusion Injury#180309ClinicalTrials.gov
• Phase 4 Study in the Elderly Patients With T2DM#181733ClinicalTrials.gov
• Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive#67829ClinicalTrials.gov
• Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics#158132ClinicalTrials.gov
• A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease#181667ClinicalTrials.gov
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both#181745ClinicalTrials.gov
• Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk#121248ClinicalTrials.gov
• Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes#143774ClinicalTrials.gov
• The Interaction Between Diabetes and Estradiol on Human Brain Metabolism in Postmenopausal Women#148631ClinicalTrials.gov